Clinical Trial Update: GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of Radiation and Yervoy (ipilimumab) in melanoma patients with brain metastases has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Drugs mentioned

• Yervoy (ipilimumab)

Snippet

Sponsor: Grupo Español Multidisciplinar de Melanoma | Conditions: Melanoma, Brain Metastases | Phase 2 | Status: COMPLETED | Results posted: 2021-07-01